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Abstract
Background: Genome-wide DNA methylation (DNAm) profiling has allowed for the development of molecular
predictors for a multitude of traits and diseases. Such predictors may be more accurate than the self-reported
phenotypes and could have clinical applications.
Results: Here, penalized regression models are used to develop DNAm predictors for ten modifiable health and
lifestyle factors in a cohort of 5087 individuals. Using an independent test cohort comprising 895 individuals, the
proportion of phenotypic variance explained in each trait is examined for DNAm-based and genetic predictors.
Receiver operator characteristic curves are generated to investigate the predictive performance of DNAm-based
predictors, using dichotomized phenotypes. The relationship between DNAm scores and all-cause mortality
(n = 212 events) is assessed via Cox proportional hazards models. DNAm predictors for smoking, alcohol, education,
and waist-to-hip ratio are shown to predict mortality in multivariate models. The predictors show moderate
discrimination of obesity, alcohol consumption, and HDL cholesterol. There is excellent discrimination of current
smoking status, poorer discrimination of college-educated individuals and those with high total cholesterol, LDL
with remnant cholesterol, and total:HDL cholesterol ratios.
Conclusions: DNAm predictors correlate with lifestyle factors that are associated with health and mortality. They
may supplement DNAm-based predictors of age to identify the lifestyle profiles of individuals and predict disease
risk.
Keywords: DNA methylation, Polygenic scores, Prediction, Ageing, Mortality
Background
DNA-based predictors of health and lifestyle have poten-
tial uses in both clinical and non-clinical contexts. For
example, biological predictors of smoking status and
alcohol consumption may provide more accurate mea-
surements than self-report, thereby improving disease
prediction and risk stratification [1]. Here, using whole
blood-derived samples, we develop ten novel DNA
methylation-based predictors of modifiable health and
lifestyle factors including alcohol consumption, smoking
status, body mass index (BMI), waist-to-hip ratio, four
measures of cholesterol, percentage body fat, and educa-
tional attainment. We then relate these predictors to both
a health outcome (mortality) and lifestyle characteristics
in an independent cohort.
DNA methylation (DNAm) is a commonly studied epi-
genetic modification characterized by chemical changes to
DNA, typically at a cytosine-phosphate-guanine (CpG)
nucleotide base pairing [2]. These modifications are dy-
namic, tissue-specific, and cell-specific [3], are involved in
gene regulation, and can be influenced by both genes and
the environment [4].
Through large meta-analysis projects, methylation sig-
nals at individual CpG sites have been associated with
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educational attainment, smoking, alcohol consumption,
cholesterol levels, and BMI [5–13]. Such studies have also
used methylation predictors (from a combination of CpG
sites) to predict the phenotype of interest in independent
cohorts. For example, 7% of the variance in BMI and 2%
of the variance in educational attainment can be explained
by their respective predictors [5, 14]. Moreover, DNA
methylation has been reported to explain 0.74% and 9.51%
of the variation in total and high-density lipoprotein
(HDL) cholesterol levels, respectively [11]. Studies have
also combined genetic risk scores into their prediction
models, showing that the DNAm predictors contribute
independently to the variance explained in BMI and
C-reactive protein levels [14, 15]. Moreover, single CpG
sites and DNAm predictors of smoking have been linked
to lung cancer/mortality [16], while DNAm-based predic-
tors of BMI and inflammation have been linked to cardio-
metabolic traits [7, 15].
There are, however, several limitations to existing
studies. First, the CpG weights for the predictors are de-
rived separately for each CpG, which does not account
for their inter-correlations. Second, large samples are
required to generate precise weights. This has meant
conducting meta-analyses with data from heterogeneous
populations where different quality control metrics have
been applied. Third, the CpG prediction weights are typ-
ically based on Z-scores rather than effect sizes, that is,
the trait was modelled as the predictor with the CpG as
the outcome in the epigenome-wide association studies
(EWASs). These Z-score weights are equivalent to model-
ling by p values, which do not account for the magnitude
of the CpG-trait association. Fourth, arbitrary significance
threshold cut-offs are used to select the number of CpGs
used in each predictor rather than training a predictor on
an optimized set of CpGs.
Here, we overcome the above limitations as de-
scribed below. We model all CpGs simultaneously in a
single large cohort of over 5000 individuals. We model
the traits of interest as the outcomes and the CpGs as
the predictors and train optimized predictors using
penalized regression methods. We then apply these
predictors to an independent cohort study of approxi-
mately 900 individuals to determine: (1) the propor-
tion of variance the DNAm predictors explain in the
outcomes; (2) the extent to which these proportions
are independent from the contribution of genetics; (3)
the accuracy with which the DNAm predictors can
identify obese individuals, college-educated individ-
uals, heavy drinkers, high cholesterol levels, and
current smokers if provided with a random DNA sam-
ple from the population; and (4) the extent to which
they can predict health outcomes, such as mortality,
and if they do so independently from the phenotypic
measure.
Results
Summary information on the ten phenotypes in both the
training (Generation Scotland: The Scottish Family
Health Study [GS]) and test (The Lothian Birth Cohort
1936 [LBC1936]) datasets is presented in Table 1.
LBC1936 is an older cohort than GS (mean age 70 vs
49 years), with a more even gender balance (51% vs 39%
male). LBC1936, when compared with GS participants,
had around two fewer years of education, were of similar
mean BMI (both cohort means were ~ 27 kg/m2), drank
slightly less alcohol (median difference of 3 units per
week), had a lower ratio of current to never smokers
(20% vs 27%), lower levels of low-density lipoprotein
(LDL) (with remnant) cholesterol (mean difference of
0.3 mmol/L), higher total cholesterol (mean difference of
0.3 mmol/L) a higher ratio of total:HDL cholesterol (mean
difference of 0.1), and similar levels of HDL cholesterol
(mean level of 1.5 mmol/L).
The LASSO regressions returned predictors based on
204–1109 CpGs. The regression weights for the predic-
tors are shown in Additional file 1: Tables S1–S10.
DNAm predictors for the ten variables were created in
LBC1936 at the baseline wave, at a mean age of approxi-
mately 70 years (n = 895).
Correlations between the phenotypic measures in GS
are presented in Additional file 2: Figure S1. Correlations
between the phenotypic measures, genetic measures, and
DNAm predictors in LBC1936 are presented in
Additional file 2: Figures S2–S4. Strong correlations were
seen between the DNAm scores for cholesterol variables
(r = − 0.6–0.8) and BMI and body fat percentage (r = 0.9).
There was a negative correlation between DNAm scores
for smoking and education (r = − 0.5). The phenotypic
smoking:DNAm education association was of a similar
magnitude (r = − 0.4) Correlations between polygenic
scores were generally weak, with the exception of
scores for LDL with remnant cholesterol and total
cholesterol (r = 0.8), and BMI and body fat percentage
(r = 0.4).
DNAm predictors explain phenotypic variation
Age and sex-adjusted linear regression models showed
that the DNAm predictors, which were developed in GS,
explained a small proportion of the phenotypic variance
in educational attainment, total cholesterol, cholesterol
ratios, and LDL with remnant cholesterol (0.6–4.5%); a
moderate proportion of the variance in BMI, HDL chol-
esterol, and alcohol consumption (12.5–15.6%); and a
high proportion of the variance in smoking (60.9%;
Table 2; Fig. 1).
The corresponding polygenic scores explained a small
proportion of the phenotypic variance in alcohol con-
sumption, education, smoking, and total cholesterol, HDL
cholesterol, and LDL with remnant cholesterol (0.7–4.0%).
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A moderate proportion of the phenotypic variance in BMI
was explained by the BMI polygenic score (10.1%; Table 2;
Fig. 1). Models including both the DNAm predictor and
the polygenic score explained the most variance in each
trait (Table 2; Fig. 1).
Phenotypes for body fat percentage and waist-to-hip
ratio were not available in LBC1936. It was therefore not
possible to assess the proportion of phenotypic variance
explained by their DNAm and polygenic scores. More-
over, due to the absence of GWAS data for total:HDL
cholesterol ratios, it was only possible to assess the
proportion of variance explained by its DNAm score.
DNAm predictors classify phenotype extremes
For the area under the curve (AUC) analyses that pre-
dicted the binary classified phenotypes in LBC1936,
there were 652 controls and 242 cases for obesity, 745
light-to-moderate drinkers and 150 heavy drinkers, 418
non-smokers and 102 current smokers, and 229 and 666
individuals with > 11 and ≤ 11 years of full-time educa-
tion, respectively. Following dichotomization of the
cholesterol-related variables, there were 531 and 354
individuals with high and low total cholesterol, re-
spectively; 89 and 723 individuals with high and low
HDL cholesterol, respectively; 637 and 175 individuals
with high and low LDL with remnant cholesterol,
respectively; and 307 and 502 with high and low
total:HDL cholesterol ratios, respectively. There was
near-perfect discriminatory power for the identifica-
tion of current smokers (AUC = 0.98; 95% confidence
Table 2 Predicting LBC1936 phenotypes using methylation and







BMI (kg/m2) 12.5 10.1 19.7
Alcohol (units per week) 12.5 0.7 13.0
Smoking (current/ever/never) 60.9 2.8 61.4
Educational attainment (years) 2.5 4.0 5.9
Total cholesterol (mmol/L) 2.7 1.1 3.6




Total:HDL cholesterol ratio 4.5 – –
Waist-to-hip ratio – – –
Body fat (%) – – –
For each trait, the proportion of phenotypic variance explained is presented
for DNAm score, polygenic score, and combined DNAm + polygenic scores for
health and lifestyle factors
Table 1 Summary of the Generation Scotland (GS) and Lothian Birth Cohort 1936 (LBC1936) studies
GS LBC 1936
N Mean SD N Mean SD
Age (years) 5087 48.5 14.0 895 69.6 0.8
Body mass index (kg/m2) 5036 27.0 5.2 894 27.8 4.4
Total cholesterol (mmol/L) 4200 5.1 1.1 885 5.4 1.2
HDL cholesterol (mmol/L) 4192 1.5 0.4 812 1.5 0.4
LDL with remnant cholesterol (mmol/L) 4192 3.6 1.1 812 3.9 1.1
Total:HDL cholesterol ratio (ratio) 4192 3.7 1.2 809 3.8 1.1
Waist-to-hip ratio (ratio) 4984 0.9 0.1 – – –
Body fat (%) 4950 30.8 9.6 – – –
N Median Q1, Q3 N Median Q1, Q3
Alcohol (units per week) 2819 8 2, 15 895 5 0.5, 14
Education (years)* 4804 12–13 10–11, 16–17 895 10 10, 12
N % N %
Sex
Male 1956 38.5 453 50.6
Female 3131 61.5 442 49.4
Smoking
Never smoked 2523 73.3 418 46.7
Ex-smoker – – 375 41.9
Current smoker 921 26.7 102 11.4
Sample counts are provided for age, sex, and measures for health and lifestyle factors in both the GS and LBC1936 studies
*Education was measured as an ordinal variable: 0, 0 years; 1, 1–4 years; 2, 5–9 years; 3, 10–11 years; 4, 12–13 years; 5, 14–15 years; 6, 16–17 years; 7, 18–19 years;
8, 20–21 years; 9, 22–23 years; 10, ≥ 24 years
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interval [CI] = 0.97–1.00, Fig. 2) and moderate discrim-
ination of obesity from non-obesity (AUC = 0.67; 95%
CI = 0.63–0.71), high HDL levels from low HDL levels
(AUC= 0.70, 95% CI = 0.64–0.75,) and of light-to-moderate
drinkers from heavy drinkers (AUC = 0.73; 95% CI =
0.69–0.78). There was poor discrimination of those
with more years of full-time education (AUC = 0.59;
95% CI = 0.55–0.63, Fig. 2), and higher total choles-
terol, LDL with remnant cholesterol and total:HDL
cholesterol ratios (total cholesterol AUC = 0.61; 95%
CI = 0.57–0.64; LDL with remnant cholesterol AUC =
0.53; 95% CI = 0.48–0.58; total:HDL cholesterol ratio
AUC = 0.61, 95% CI = 0.57–0.65). Including the poly-
genic scores in addition to the DNAm predictors im-
proved the prediction of all traits, with the exception
of alcohol consumption and total cholesterol (Add-
itional file 3: Table S11). The smoking DNAm pre-
dictor was a significant addition to a logistic
regression model for the binary education measure
(smoking DNAm p = 0.006, education DNAm p = 0.08,
and polygenic education p = 1.4 × 10−8) and high/low
total cholesterol (smoking DNAm p = 0.033, total
cholesterol DNAm p = 1.0 × 10−6, polygenic total
cholesterol p = 0.014).
DNAm predictors and mortality
Mortality in LBC1936 was assessed in relation to pheno-
type, DNAm scores, and polygenic scores using Cox
proportional-hazards models, adjusting for age, sex, white
blood cell proportions and each trait’s corresponding
phenotype and polygenic score, where applicable
(Additional file 3: Table S12 and Fig. 3). There were 212
deaths from 895 participants over 12 years of follow-up.
Higher phenotypic former smoking status (compared to
never smokers) were associated with higher mortality risk
(hazard ratio [HR] 1.45, 95% CI = 1.01–2.07, p = 0.044). A
mild protective effect was associated with higher total
cholesterol (HR = 0.86, 95% CI = 0.74–1.00, p = 0.047). No
significant associations were observed in LBC1936 be-
tween risk of mortality and phenotypic BMI, alcohol
consumption, educational attainment, or the remaining
cholesterol-related variables. A significant association
was observed between mortality and the polygenic
score for body fat percentage (HR = 1.18, 95% CI =
1.03–1.36, p = 0.016) but not for the other eight genetic
scores. Higher mortality risk was associated with higher
DNAm scores for smoking (HR = 1.29, 95% CI = 1.05–1.57,
p = 0.013), waist-to-hip ratio (HR = 1.24, 95% CI = 1.08–
















Fig. 1 DNAm and polygenic prediction of health and lifestyle factors. Proportion of phenotypic variance explained (R2) is plotted for eight traits:
BMI; smoking; alcohol consumption (alcohol); education; total cholesterol (TC); HDL cholesterol (HDL); LDL with remnant cholesterol (LDL); and
total:HDL cholesterol ratio (TC:HDL) based on each trait’s polygenic score (blue), DNA methylation-based score (green), and additive genetic +
epigenetic score (orange)
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Fig. 3 HRs for epigenetic (DNAm) predictors of mortality. Forest plots show HRs for DNAm scores for health and lifestyle factors. Effect sizes are
per standard deviation with the exception of phenotypic smoking, for which never smokers are used as a reference group. Horizontal lines
represent 95% CIs
Fig. 2 ROC analysis for DNAm predictors of alcohol, smoking, education, BMI, and cholesterol-related variables. Shown are ROC curves for
predicting alcohol consumption, smoking status, obesity, and education (left), and cholesterol levels (right) Obese and non-obese are defined as
BMI > 30 and≤ 30 kg/m2; moderate-to-heavy and non-to-light drinkers defined as drinking > 21 and≤ 21 units (men) or > 14 and≤ 14 units
(women) of alcohol per week; highly educated individuals had > 11 years of full-time education, compared to low-to-average education (≤ 11 years).
High cholesterol levels were defined based on NHS guidelines (https://www.nhs.uk/conditions/high-cholesterol/: > 5 mmol/L for total
cholesterol, > 3 mmol/L for LDL cholesterol, > 1 mmol/L for HDL cholesterol, and ≥ 4 for total:HDL cholesterol ratios)
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CI = 1.08–1.43, p = 0.003). A higher DNAm score for edu-
cation was associated with lower mortality risk (HR = 0.81.
95% CI = 0.71–0.93, p = 0.004). Following correction for
multiple testing, DNAm signatures for education, alcohol
consumption, and waist-to-hip ratio remained significantly
associated with mortality (p < 0.05/10 = 0.005).
A final set of nine survival models were considered.
These covaried for the smoking DNAm predictor alongside
the covariates listed above (Table 3). Both the phenotypic
BMI and smoking DNAm predictor were significant pre-
dictors of mortality (BMI HR= 1.23, 95% CI = 1.06–1.42, p
= 0.005; DNAm smoking HR= 1.57, 95% CI = 1.39–1.78, p
= 8.3 × 10−13). The association between the waist-to-hip ra-
tio DNAm predictor and mortality remained after condi-
tioning on the smoking DNAm predictor (p = 0.012).
However, conditioning on the smoking DNAm pre-
dictor attenuated the association between the both
the alcohol consumption and education DNAm
Table 3 Cox proportional hazards survival models output for phenotypic, epigenetic (DNAm), and genetic (polygenic) predictors of
health and lifestyle factors, conditioned on the smoking DNAm score
Trait Predictor HR 95% CI P
Alcohol Phenotypic 0.95 0.83–1.09 0.457
Epigenetic 1.11 0.97–1.28 0.134
Genetic 1.02 0.90–1.17 0.27
Smoking DNAm 1.46 1.29–1.65 1.4 × 10−9
Education Phenotypic 0.93 0.81–1.08 0.352
Epigenetic 1.00 0.85–1.17 0.979
Genetic 0.95 0.82–1.10 0.474
Smoking DNAm 1.48 1.29–1.70 1.8 × 10−8
BMI Phenotypic 1.23 1.06–1.42 0.005
Epigenetic 1.04 0.90–1.20 0.614
Genetic 1.09 0.94–1.26 0.263
Smoking DNAm 1.57 1.39–1.78 8.3 × 10−13
Total cholesterol Phenotypic 0.85 0.73–0.99 0.031
Epigenetic 0.95 0.81–1.12 0.542
Genetic 1.11 0.96–1.27 0.155
Smoking DNAm 1.49 1.32–1.68 9.7 × 10−11
HDL cholesterol Phenotypic 0.92 0.77–1.09 0.318
Epigenetic 0.92 0.78–1.08 0.307
Genetic 1.08 0.94–1.25 0.277
Smoking DNAm 1.48 1.31–1.67 3.0 × 10−10
LDL with remnant cholesterol Phenotypic 0.89 0.77–1.03 0.122
Epigenetic 0.99 0.84–1.17 0.910
Genetic 1.08 0.93–1.25 0.303
Smoking DNAm 1.49 1.31–1.68 3.3 × 10−10
Total:HDL cholesterol ratio Phenotypic 0.99 0.85–1.15 0.870
Epigenetic 1.12 0.95–1.30 0.170
Smoking DNAm 1.48 1.30–1.67 6.9 × 10−10
Waist-to-hip ratio Epigenetic 1.20 1.04–1.39 0.012
Genetic 0.94 0.82–1.07 0.361
Smoking DNAm 1.47 1.31–1.66 1.3 × 10−10
Body fat percentage Epigenetic 1.11 0.96–1.27 0.147
Genetic 1.19 1.04–1.36 0.013
Smoking DNAm 1.51 1.34–1.70 1.1 × 10−11
Cox proportional hazards outputs are presented for models adjusting for age, sex, phenotypes (where applicable), polygenic scores (where applicable), white
blood cell counts, and smoking DNAm scores. All effect sizes are per standard deviation
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predictors and mortality (alcohol consumption p =
0.134, education p = 0.352). Forest plots for pheno-
typic and genetic scores are available in Add-
itional file 2: Figures S5 and S6.
Discussion
We have identified DNA methylation-based predictors
for ten modifiable lifestyle and health factors that: (1)
explain varying degrees of proportions of their pheno-
typic variance and do so independently from corre-
sponding genetic predictors; (2) help to characterize
individual differences; and (3) show association with a
clinically relevant outcome through prediction of mor-
tality and do so independently from phenotypic and
genetic measures.
The DNAm predictors explained different proportions
of the variance in the modifiable complex traits, from
0.6% for LDL with remnant cholesterol up to 60.9% for
smoking. By combining genetic and epigenetic predic-
tors we were able to augment these predictions. The
previous best estimate for genetic plus epigenetic BMI
prediction was ~ 15% [14]. The combined predictor in
the current study was able to explain nearly 20% of the
variance in BMI. The alcohol consumption, HDL choles-
terol, and smoking predictions were largely driven by
the DNAm predictors whereas the LDL with remnant
cholesterol prediction was largely driven by the genetic
predictor for LDL cholesterol.
There is near-perfect discrimination between current
and never smokers based on the smoking DNAm pre-
dictor and moderate discrimination between obese indi-
viduals, moderate-to-heavy drinkers, and individuals
with high HDL cholesterol levels. Differentiating those
with a high level of education is more a function of
genetics than DNAm, although the combined predictive
power remains poor. In the case of some phenotypes,
the varying discriminatory abilities of their DNAm
scores may be attributed to degree, duration, and/or
time of exposure. Misclassification of lighter drinkers as
heavy drinkers based on DNAm score may be reflective
of effects of recent or infrequent above-average alcohol
consumption. This highlights a potential application of
DNAm-based signatures as proxies for self-reported
phenotypes. In the case of current smokers, cigarette
smoke is likely to be a constant exposure up to the time
of sampling, which may reflect the high sensitivity of the
DNAm-based smoking score. Former smokers display a
DNAm score intermediate score relative to that of
current and never smokers, which may reflect a degree
of temporality in the smoking DNAm score (Additional
file 2: Figure S7). Application of these predictors along-
side existing DNAm-based age predictors [17, 18] may
also be of use in forensic investigations, given an unknown
blood sample [19].
As with the previous EWAS analysis of education [5],
there is a strong overlap with smoking-related methyla-
tion signals. The strength of the correlation between the
education and smoking DNAm predictors (r = − 0.49) is
particularly interesting when placed in context with their
more modest phenotypic correlation (r = − 0.14). Given
that DNA methylation is highly predictive of smoking
status [9], it may be the case that, should a single
smoking-sensitive CpG feature in a DNAm predictor for
another trait—here, education—then this drives a high
correlation between the two DNAm predictors. Notably,
previously reported DNAm-based biomarkers of BMI
(e.g. cg11024682 [7]), total cholesterol (e.g. cg16000331
[11]), smoking (e.g. cg05575921 [9]), and HDL choles-
terol (e.g. cg17901584 [10]) were among the features
with the largest absolute coefficients in their respective
models. It is also of note that the DNAm predictor for
education contained established DNAm-based biomarkers
of smoking from the AHRR gene (cg11902777 and
cg05575921 [9]). A DNAm education predictor excluding
this feature/CpG was strongly correlated with the primary
predictor (r = 0.996). Correlations between different CpG
features within each of the DNAm predictors may be re-
sponsible for the association observed between predictors.
The survival analysis in the out-of-sample prediction
LBC1936 cohort yielded significant associations for the
smoking, alcohol, waist-to-hip ratio, and education DNAm
predictors. When included as a covariate, the smoking
DNAm predictor attenuated the DNAm-mortality associa-
tions for both the education and alcohol predictors, but not
the predictor for waist-to-hip ratio. In the case of pheno-
typic alcohol consumption and education, there were no
associations with all-cause mortality. This may suggest
these scores are capturing additional factors related to their
corresponding phenotypes (such as smoking), which may
have more direct biological consequences that contribute
to risk of mortality. The DNAm score for education, for
example, was correlated with phenotypic smoking status.
Consistent with our phenotype-based survival analyses,
others have reported positive associations between mortal-
ity risk and smoking [20, 21] whereas higher educational
attainment and old-age total cholesterol levels have been
associated with a decreased mortality risk [22–25]. More-
over, a recent meta-analysis failed to find a significant
relationship between phenotypic alcohol consumption and
all-cause mortality [26].
It should be noted that the polygenic score used to
predict LDL with remnant cholesterol was derived from
a GWAS of LDL cholesterol only. Both DNAm and gen-
etic scores explained a small proportion of the variance
in LDL with remnant cholesterol while the predictive
performance of high versus low LDL with remnant chol-
esterol (based on guidelines for LDL cholesterol only)
was poor. It is possible that the heterogeneity of the
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phenotype (calculated from the difference between mea-
sured total and HDL cholesterol) posed a limitation in the
development of a reliable DNAm-based signature. De-
veloping DNAm-based predictors of LDL and remnant
cholesterol using separate measurements of LDL and
remnant cholesterol may be a more successful strategy
for future studies.
There are two key strengths to this study. First, the
sample size of the GS cohort, which is one of the single
largest epidemiological cohort studies with DNA methy-
lation data, enabled us to improve on previous DNAm
predictors by: modelling all CpG sites simultaneously;
training the predictor using cross-validation penalized re-
gression modelling; and reducing heterogeneity in both
phenotypic and methylation measurement through a single
data collection and analysis protocol. Second, we could
predict not only the relevant phenotypes of interest but
also a clinically meaningful outcome (mortality) in our
large, genetically homogenous, out-of-sample prediction
cohort, LBC1936. Other studies with DNA methylation
data and longitudinal disease follow-up for, for example,
cardiometabolic, cardiovascular, and cancer-related out-
comes will be able to further test the predictive perform-
ance of our DNAm predictors.
The GS cohort contained related individuals who may be
more phenotypically similar for the traits under investiga-
tion. Residuals from sensitivity analyses that adjusted the
phenotypes for pedigree structure as a random effect, in
addition to age, sex, and population stratification as fixed
effects, correlated highly (minimum Pearson r = 0.96) to
those from the models without pedigree adjustment. The
older age range of LBC1936 and longitudinal follow-up
enabled us to examine the ability of DNAm-based pre-
dictors for complex traits to predict mortality, inde-
pendently of the phenotypes themselves. As mentioned
previously, the test cohort was older, had fewer years of
education, were lighter drinkers, heavier smokers rela-
tive to the training cohort, had lower levels of total
cholesterol and LDL (with remnant) cholesterol, and a
lower total:HDL cholesterol ratio. The DNAm predic-
tors may perform differently on these measures in co-
horts that are more analogous in age and phenotypic
distribution to the training dataset, GS.
Conclusions
In summary, we showed that DNAm predictors are
able to predict modifiable health and lifestyle factors
with some success. They can also augment phenotypic
prediction of mortality. Future studies should focus
on other incident health outcomes, such as cardio-
metabolic disease and cancer. There is scope to use
these DNAm predictors, in addition to DNAm-based
predictors of age, to help identify lifestyle characteristics
from DNA.
Methods
Training dataset for the DNAm predictors: Generation
Scotland
The DNAm predictors were built on a subset of 5087 in-
dividuals from GS, who had DNA methylation measured
as part of a sub-study: Stratifying Resilience and Depres-
sion Longitudinally (STRADL). The parent cohort, GS,
contains detailed cognitive, physical, health, and genetic
data on over 22,000 individuals from across Scotland,
aged 18–99 years [27, 28]. It is a family-structured,
population-based longitudinal cohort study. Stored DNA
samples from bloods collected at the study baseline
(2006–2011) were used for the DNAm analysis.
Methylation preparation in Generation Scotland
Quality control was performed on Illumina Human-
MethylationEPIC BeadChip DNA methylation data
from blood samples of 5200 individuals from the GS
cohort. Details have been reported previously [29].
Three individuals who had answered “yes” to all
self-reported conditions were excluded from the ana-
lysis. Filtering for outliers, sex mismatches, non-blood
samples, poorly detected probes, and samples was per-
formed. A full description is provided in Additional file 4.
Further filtering was then carried out to remove CpGs
with missing values, non-autosomal and non-CpG
sites, and any sites not present on the Illumina 450 k
array. The latter criterion enabled prediction into the LBC
study.
Phenotype preparation in Generation Scotland
We considered ten phenotypes from GS for the analysis:
educational attainment; BMI; total cholesterol; HDL
cholesterol; LDL with remnant cholesterol; total:HDL
cholesterol ratio; waist-to-hip ratio; percentage body fat;
and self-reported alcohol consumption and smoking
status. Phenotypes for LDL with remnant cholesterol
were calculated as the difference between total choles-
terol and HDL cholesterol. Educational attainment was
assessed on an ordinal scale, the other traits were
assessed as continuous traits and in their standard units
of measurement with pack years for smoking and units
per week for alcohol (full details in Additional file 4).
Each phenotype was then regressed on age, sex, and
ten genetic principal components [30] with the residuals
being entered as the dependent variable in the LASSO
models.
LASSO regression in Generation Scotland
Penalized regression models were run using the glmnet
library in R [31, 32]. Tenfold cross-validation was ap-
plied and the mixing parameter (alpha) was set to 1 to
apply a LASSO penalty. Coefficients for the model with
the lambda value corresponding to the minimum mean
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cross-validated error were extracted and applied to the
corresponding CpGs in an out of sample prediction cohort
to create the DNAm predictors.
The out-of-sample prediction cohort: Lothian Birth
Cohort 1936
LBC1936 [33, 34] was used for external DNAm predic-
tions. LBC1936 is a cohort comprising individuals born
in 1936, who were aged approximately 70 years at re-
cruitment. Here, DNAm was assessed in blood samples
from wave 1 of the study between 2004 and 2007.
Methylation preparation in the Lothian Birth Cohort 1936
DNAm from whole blood was assessed in the LBC1936
using the Illumina 450 k methylation array. Over 90% of
the 450 k CpG sites are present on the EPIC array. Qual-
ity control details have been reported previously [35]
and are detailed in Additional file 4.
Polygenic scoring in the Lothian Birth Cohort 1936
Polygenic scores were created in LBC1936 using PRSice
[36] with clumping parameters of R2 > 0.25 over 250-kb
sliding windows. Genotyped data were generated at the
Wellcome Trust Clinical Research Facility using the Illu-
mina 610-Quadc1 array (San Diego, CA, USA). The SNP
weights for all variants (p < 1) for the traits [37–43] were
taken from large genome-wide association studies (GWAS).
Where LBC1936 was included in the discovery GWAS
(educational attainment [40]), the meta-analysis was re-run
after its exclusion.
Phenotypes in the Lothian Birth Cohort 1936
Phenotype measurement details in LBC1936 are as follows:
self-reported smoking status (current smoker, ex-smoker,
never smoked); alcohol consumption in a typical week
(recoded into units); and education (years of full-time
education) were assessed along with BMI (defined as the
ratio of weight in kg divided by height in m2); total choles-
terol; HDL cholesterol; LDL with remnant cholesterol (all
in mmol/L); total:HDL cholesterol ratio; waist-to-hip ratio;
and percentage body fat. LDL with remnant cholesterol
was defined as the difference between total cholesterol
and HDL cholesterol. Binary categorizations of smoking
(current versus never), BMI (> 30 vs ≤ 30 kg/m2, de-
fined as obese and non-obese, respectively), education
(> 11 vs ≤11 years, which is roughly equivalent to a
college education level for LBC1936), and alcohol con-
sumption were used as outcomes for receiver operating
characteristic (ROC) curve analyses. Cholesterol-related
variables were dichotomized as high or low based on
NHS guidelines on cholesterol levels (https://www.nhs.
uk/conditions/high-cholesterol/): > 5 mmol/L for total
cholesterol, > 3 mmol/L for LDL with remnant
cholesterol, > 1 mmol/L for HDL cholesterol, and ≥ 4
for total:HDL cholesterol ratios. Sex-specific dichoto-
mizations were applied to the alcohol consumption
phenotype, as per UK health recommendations at the
time of data collection (≤ 21 vs > 21 units per week for
men, and ≤ 14 vs > 14 units per week for women; corre-
sponding to moderate and heavy alcohol consumption
in each gender, respectively. Mortality data were ob-
tained through data linkage to the National Health Ser-
vice Central Register, provided by the General Register
Office for Scotland (now National Records of Scotland).
The mortality data used in the present analysis were
correct as of January 2018.
Prediction analysis in the Lothian Birth Cohort 1936
Area under the curve (AUC) estimates were estimated
for binary categorizations of BMI, smoking, alcohol con-
sumption, college education, and cholesterol variables.
Linear regression models were used to identify the pro-
portion of phenotypic variance explained by the corre-
sponding DNAm predictor and to determine whether
this was independent of the polygenic (genetic) signal
for each phenotype. Ordinal logistic regression was used
for the categorical smoking variable (never, ex, current
smoker). Age and sex were considered as covariates, the
phenotypic measure was the dependent variable, and the
polygenic score or DNAm predictor were the independ-
ent variables of interest. Incremental R2 estimates were
calculated between the null model and the models with
the predictors of interest. An additive genetic and epi-
genetic model for BMI in the LBC1936 has been re-
ported previously, although a different DNAm predictor,
based on unrelated individuals, was derived from the GS
data [44]. ROC curves were developed for smoking sta-
tus, obesity, high/low alcohol consumption, college edu-
cation and cholesterol variables, and AUC estimates
were estimated for binary categorizations of these vari-
ables using the pROC library in R [45]. Cox proportional
hazards survival models [46] were used to examine
whether the phenotype, polygenic score, or DNAm pre-
dictor explained mortality risk and if they do so inde-
pendently of one another. Sex was included as a
covariate in all models. Correction for multiple testing
was applied using the Bonferroni method.
Additional files
Additional file 1: DNAm signature CpGs and corresponding weights for
BMI (Table S1), smoking (Table S2), alcohol consumption (Table S3),
educational attainment (Table S4), total cholesterol (Table S5), HDL
cholesterol (Table S6), LDL (with remnant) cholesterol (Table S7),
Total:HDL cholesterol ratio (Table S8), waist-to-hip ratio (Table S9), and
percentage body fat (Table S10). (XLSX 159 kb)
Additional file 2: Figure S1. Correlations between phenotypes in GS
samples. Figure S2. Correlations between phenotypes in LBC1936
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samples. Figure S3. Correlations between DNA methylation scores in
LBC1936 samples. Figure S4. Correlations between genetic scores in
LBC1936 samples. Figure S5. HRs for phenotypic predictors of mortality
in LBC1936 samples. Figure S6. HRs for polygenic predictors of mortality
in LBC1936 samples. Figure S7. DNA methylation scores for current,
former, and never smokers in LBC1936. (PDF 382 kb)
Additional file 3: Table S11. Prediction of traits with and without
genetic scores. Table S12. Cox proportional hazards survival models
output for phenotypic, epigenetic (DNAm), and genetic (polygenic)
predictors of health and lifestyle factors. (XLSX 14 kb)
Additional file 4: Document contains further information on phenotype
preparation and quality control of DNAm data for GS and LBC1936.
(PDF 90 kb)
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